M Type 1 and 3 Group A Streptococci Stimulate Tissue Factor-Mediated Procoagulant Activity in Human Monocytes and Endothelial Cells
Open Access
- 1 April 2003
- journal article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 71 (4) , 1903-1910
- https://doi.org/10.1128/iai.71.4.1903-1910.2003
Abstract
Streptococcal toxic shock syndrome (StrepTSS) is an invasive infection characterized by marked coagulopathy, multiple organ failure, and rapid tissue destruction and is strongly associated with M type 1 and 3 group A streptococci (GAS). Initiation of the coagulation cascade with formation of microvascular thrombi contributes to multiple organ failure in human cases of gram-negative bacteremia; however, little is known regarding the mechanism of coagulopathy in StrepTSS. Thus, we investigated the abilities of several strains of M type 1 and 3 GAS isolated from human cases of StrepTSS to stimulate production of tissue factor (TF), the principal initiator of coagulation in vivo. Washed, killed M type 1 and 3 GAS, but not M type 6 GAS, elicited high-level TF-mediated procoagulant activity from both isolated human monocytes and cultured human umbilical vein endothelial cells. M type 1 GAS consistently elicited higher levels of TF from monocytes than did M type 3 GAS. GAS-induced TF synthesis in monocytes did not correlate with production of tumor necrosis factor alpha or interleukin-8. Conversely, M type 3 GAS were consistently more potent than M type 1 GAS in stimulating endothelial cell TF synthesis. These results demonstrate that (i) M type 1 and 3 strains of GAS are potent inducers of TF synthesis, (ii) GAS-induced TF synthesis is not simply an epiphenomenon of cytokine generation, and (iii) induction of TF in endothelial cells and monocytes may be M type specific. In total, these findings suggest that a novel interaction between GAS and host cells contributes to the observed coagulopathy in StrepTSS.Keywords
This publication has 37 references indexed in Scilit:
- Influence of Recombination and Niche Separation on the Population Genetic Structure of the Pathogen Streptococcus pyogenesInfection and Immunity, 2002
- Variations among clinical isolates ofStaphylococcus aureusto induce expression of E-selectin and ICAM-1 in human endothelial cellsFEMS Immunology & Medical Microbiology, 2002
- Kallikrein-Kinin System Activation in Streptococcal Toxic Shock SyndromeClinical Infectious Diseases, 2000
- Review: Infectious Diseases and Coagulation DisordersThe Journal of Infectious Diseases, 1999
- Type‐Specific Opsonophagocytosis of Group A Streptococcus by Use of a Rapid Chemiluminescence AssayThe Journal of Infectious Diseases, 1999
- The Hemopexin-Type Repeats of Human Vitronectin Are Recognized byStreptococcus pyogenesBiochemical and Biophysical Research Communications, 1997
- Analysis of Plasmin(ogen) Acquisition by Clinical Isolates of Group A Streptococci Incubated in Human PlasmaThe Journal of Infectious Diseases, 1994
- Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock.Journal of Clinical Investigation, 1993
- Streptococcal Toxic Shock Syndrome: Synthesis of Tumor Necrosis Factor and Interleukin-1 by Monocytes Stimulated with Pyrogenic Exotoxin A and Streptolysin OThe Journal of Infectious Diseases, 1992
- Severe Group A Streptococcal Infections Associated with a Toxic Shock-like Syndrome and Scarlet Fever Toxin ANew England Journal of Medicine, 1989